The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer

Danijel Sikic1 Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, GermanyCorrespondence[email protected]

Helge Taubert1 Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany

https://orcid.org/0000-0002-9077-1727

Johannes Breyer3 Department of Urology, University of Regensburg, Caritas St. Josef Medical Center, Regensburg, Germany

Markus Eckstein2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany;4 Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany

Veronika Weyerer2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany;4 Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany

Bastian Keck1 Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany

Jennifer Kubon1 Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany

Wolfgang Otto3 Department of Urology, University of Regensburg, Caritas St. Josef Medical Center, Regensburg, Germany

Thomas S Worst5 Department of Urology and Urosurgery, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany

Maximilian C Kriegmair5 Department of Urology and Urosurgery, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany

Philipp Erben5 Department of Urology and Urosurgery, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany

Arndt Hartmann2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany;4 Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany

Bernd Wullich1 Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany

https://orcid.org/0000-0002-0665-6604

Ralph M Wirtz6 STRATIFYER Molecular Pathology GmbH, Cologne, Germany

Sven Wach1 Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany

show all

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer

Articles from other publishers (9)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer

Citations (9)

Articles from other publishers (9)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date